This Week in Cardiology

• Oct 25 2024 This Week in Cardiology   Listener feedback on PFA and STEMI/NSTEMI paradigm, oral semaglutide, symptomatic vs asymptomatic AF, and the win-ratio are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, October 25, 2024
• Oct 18 2024 This Week in Cardiology   Listener feedback on the c-statistic, atherosclerotic plaque imaging, WATCHMAN implant decisions in the US, and deprescribing are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, October 18, 2024
• Oct 11 2024 This Week in Cardiology   Reader feedback on cardiac devices and PFA, a new paradigm in the language of MI, sudden cardiac death, and measuring blood pressure are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, October 11, 2024
• Oct 04 2024 This Week in Cardiology   Reader feedback on LGE pre-ICDs, PFA for AF ablation, CTO-PCI, endovascular ablation of the greater splanchnic nerve in HFpEF, and data sharing are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, October 04, 2024
• Sep 27 2024 This Week in Cardiology   Surgical clearance, NICM assessment, dueling perspectives on PCI as first-line therapy for angina, GDMT in HFrEF are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, September 27, 2024
• Sep 20 2024 This Week in Cardiology   Listener feedback, K levels post cardiac surgery, cardiac device safety, disparities in preventive care, stopping trials early, and a SHAM-PVI update are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, September 20, 2024
• Sep 13 2024 This Week in Cardiology   More from ESC: the SCOFF trial and fasting before cardiac cath, MATTERHORN, humbling data with AI, plus a reflection on the work of being a patient are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, September 13, 2024
• Sep 06 2024 This Week in Cardiology   Feedback on ABYSS and beta-blockers, more ESC recap, including SHAM-PVI, FINEARTS-HF, and RESHAPE HF2 trials are the topics John Mandrola, MD, discusses in today’s podcast.
  theheart.org on Medscape, September 06, 2024
• Aug 30 2024 This Week in Cardiology   From ESC: post-MI beta blockers, a new therapy for ATTR-CM, holding RASi before non-cardiac surgery, good news in HFpEF, and an ESC preview are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, August 30, 2024
• Aug 23 2024 This Week in Cardiology   Suicidal ideation and GLP-1 agonists, a repeat of PARADIGM HF in Chagas CM, CASTLE HTx critical appraisal, and primary prevention of SCD in HF are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, August 23, 2024
• Aug 16 2024 This Week in Cardiology   Diuretic therapy in HFrEF, AF ablation, TACT 2 and the story of subgroups, and SGLT2 inhibitor underuse are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, August 16, 2024
• Aug 09 2024 This Week in Cardiology   Prediction models vs clinical judgement, CCTA quantification of atherosclerosis, AF ablation plus LAAO, atrial shunt devices, and HF medical therapy are topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, August 09, 2024
• Aug 02 2024 This Week in Cardiology   Two downsides of PFA including autonomic tone and hemolysis, a bad surrogate in AF care, and controversies in defining cardiac risk are the topics John Mandrola, MD, covers in this week's podcast.
  theheart.org on Medscape, August 02, 2024
• Jul 26 2024 This Week in Cardiology   Health and income, high BP in the hospital, and more on subclinical AF and when to use anticoagulants are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, July 26, 2024
• Jul 19 2024 This Week in Cardiology   Vulnerable plaque and scientific method; industry payments to trainees; tirzepatide or semaglutide; trial interpretation; and PFA are the topics John Mandrola, MD, covers in today’s podcast.
  theheart.org on Medscape, July 19, 2024
• Jul 12 2024 This Week in Cardiology   Venous closure devices, GLP1-s linked to blindness and cancer, resisting the urge to do an ECG, and transcatheter edge-to-edge repair (TEER) for secondary mitral regurgitation are the topics discussed this week.
  theheart.org on Medscape, July 12, 2024
• Jun 28 2024 This Week in Cardiology   Screening echo, multivitamins, wasteful research, another PA sensor for HF, vascular closure devices, and GLP-1 marketing as science research are the topics John Mandrola, MD, discusses this week.
  theheart.org on Medscape, July 01, 2024
• Jun 21 2024 This Week in Cardiology   MRAs in HF with renal dysfunction, coronary autoregulation, the hubris of US doctors, NSTEMI in older patients, survival after STEMI, and new leaders at JACC are discussed by John Mandrola, MD.
  theheart.org on Medscape, June 21, 2024
• Jun 14 2024 This Week in Cardiology   Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, June 14, 2024
• Jun 07 2024 This Week in Cardiology   Cannabis and CV outcomes, post-CABG AF, embolic protection devices, emulation of randomization, and a preview heterogenous treatment effects are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, June 07, 2024